SCHEMBL6284884

SCHEMBL6284884

Cc1ccc(C#N)c(SCCC(N)c2ccns2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
NOS2 P35228 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 9/20 0.40
KDM4E B2RXH2 6/20 0.40
LMNA P02545 3/20 0.40
POLB P06746 3/20 0.40
HSD17B10 Q99714 2/20 0.40
HTT P42858 1/20 0.40
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6285417 0.79 HDAC1 (0.38) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6050169 0.78 CYP2D6 (0.65) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6285601 0.74 CYP2D6 (0.42) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6286308 0.71 L3MBTL1 (0.43) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6188908 0.70 TDP1 (0.41) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6645849 0.69 L3MBTL1 (0.45) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6050132 0.69 NOS2 (0.46) CYP2D6SLC6A2SLC6A4NOS2L3MBTL1
SCHEMBL22957517 0.68 L3MBTL1 (0.57) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL6186905 0.67 CYP2D6 (0.40) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2
SCHEMBL4011612 0.66 L3MBTL1 (0.51) CYP2D6SLC6A2SLC6A4NOS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2005501834-A 2005-01-20 JP claimed
EP-1414802-A1 HETEROARYLHETEROALKYLAMINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NITRIC OXIDE SYNTHASE AstraZeneca AB (SE) 2004-05-06 EP claimed
WO-2003011830-A1 HETEROARYLHETEROALKYLAMINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2003-02-13 WO claimed
EP-1414802-A1 HETEROARYLHETEROALKYLAMINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NITRIC OXIDE SYNTHASE AstraZeneca AB (SE) 2004-05-06 EP disclosed
WO-2003011830-A1 HETEROARYLHETEROALKYLAMINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2003-02-13 WO disclosed